Chinese insurance companies are favouring equities listed in Hong Kong over those traded on mainland bourses this year, drawn by higher dividend yields, even when the shares are of the same company but with dual listings in Hong Kong and the mainland.
Zheshang Property and Casualty Insurance Company (Zheshang Insurance) turned profitable in 2023, and earnings continued to expand in the first nine months of this year (9M2024) on better underwriting performance, notes Fitch Ratings.
The Chinese life insurance sector is expected to chalk up mid-single digits top-line growth in 2025, after growing by 15.7% year on year in 3Q2024 due to strong sales before insurers' pricing-interest rate cuts, says Fitch Ratings.
Losses from weather-related catastrophes may destabilise the earnings of mainland Chinese non-life insurers, especially in 2H2025, according to Fitch Ratings.
The premium income of life insurance companies in China declined in the single month of October, which was the first monthly negative growth in 2024 to date, according to data from the National Financial Regulatory Administration (NFRA).
The synergy and integration between Allianz Jingdong General Insurance Company and its parent company, Allianz SE, is expected to grow in the longer term, says Fitch Ratings.
French insurance giant AXA and the People's Insurance Company (Group) of China, the country's biggest non-life insurer, have signed a Memorandum of Understanding to boost global cooperation.
The National Financial Regulatory Administration (NFRA) has approved a licence for a new insurer to be registered in the city of Suzhou in the eastern province of Jiangsu. The proposed name of the insurer is Suzhou Dongwu Property Insurance Co.
Insurance companies in China are entering the intelligent vehicle market as the proportion of new cars equipped with high-level intelligent systems increases.
Medical costs are projected to rise in mainland China by a marginally faster rate of 10.8% in gross terms in 2025, compared to 10.5% in 2024, according to the WTW Global Medical Trends Survey.